News

16th Invitation to manufacturers of antituberculosis medicines to submit an expression of interest (EOI) for product evaluation to the WHO Prequalification Team: medicines (06 March 2018)

The following products were added:

  • Bedaquiline (fumarate), tablet 100mg
     
  • Delamanid, tablet 50mg
     
  • Delamanid, tablet 50mg (dispersible)